Disease/Infection News

RSS

Inovio third quarter total revenue decreases from $3.6 million to $1.3 million

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended September 30, 2010.

15 Nov 2010

Researchers find influenza vaccines can contain allergenic components

People with egg or gelatin allergies shouldn't assume that just because they've had a flu shot safely in the past they will be able to again, according to a new study, presented at the American College of Allergy, Asthma and Immunology annual meeting in Phoenix Nov. 11-16.

15 Nov 2010

Novel light technology kills hospital superbugs

A pioneering lighting system that can kill hospital superbugs - including MRSA and C.diff - has been developed by researchers at the University of Strathclyde in Glasgow. Scotland.

15 Nov 2010

WHO endorses low tech, low cost, rapid test for multi-drug resistant TB

A rapid, low cost test for diagnosing tuberculosis (TB) - including multi-drug resistance - has been endorsed by the World Health Organisation (WHO) for use in resource-poor settings.

15 Nov 2010

Deinobiotics project receives €1.35 million for developing novel antibiotic, antifungal compounds

Deinove, the world's leading specialist in Deinococcus bacteria for biofuels, green chemistry and antibiotics, today announced that its Deinobiotics project is to receive a total of €1.35 million in grants and loans.

15 Nov 2010

Report documents increase in R&D projects on developing world diseases

Drugmakers are now working on over 100 R&D projects designed to tackle diseases of the developing world and almost 80% of them are being carried out with non-industry partners, according to a report released on Wednesday by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).

15 Nov 2010

New findings on HIV can help validate structure-based drug design approach

The development of new drugs to treat and prevent HIV/AIDS depends on understanding the basic biology of how the virus infects human cells. For 25 years, researchers supported primarily by NIH's National Institute of General Medical Sciences (NIGMS) have been generating the structures of key viral proteins, revealing important insights into the virus's mechanisms and, more importantly, its Achilles' heels.

15 Nov 2010

Research on E.Coli bacteria could help develop new vaccine for urinary tract infection

Urinary tract infections are a painful, recurring problem for millions of women. They are also getting more dangerous as bacteria develop resistance to the most common treatments.

15 Nov 2010

Immunitor completes V5 Phase IIb imm01 clinical trial enrollment for TB

Immune Network Ltd., advises that its potential acquisition, Immunitor USA Inc., has announced the completion of enrollment in its Phase IIb imm01 clinical trial of V5 in tuberculosis.

15 Nov 2010

Pneumonia Report Card shows prevention, treatment tools not widely adopted in countries where disease kills most children

In advance of World Pneumonia Day, the International Vaccine Access Center (IVAC) on Thursday released a report card showing that pneumonia prevention and intervention targets are not being met in the 15 countries where three-quarters of deaths in children under age 5 from the disease occur each year, IRIN reports.

14 Nov 2010

U.N. agencies, Rotary International launch mass polio immunization campaign in Central Africa

The WHO, UNICEF and Rotary International on Thursday announced they will kick off a "mass polio immunization campaign in three Central African nations" on Friday "in response to a polio outbreak suspected in more than 100 deaths and deemed 'unusual' because it targets adults more than children," the Associated Press reports.

14 Nov 2010

Australian epidemics research programme to be disbanded

The Australian Federal Government scrapped the funding to the Australian National University’s Master of Applied Epidemiology (MAE) program. This group helps Australia’s response to major disease outbreak and will be disbanded at the end of next year. According to Emeritus Professor Robert Douglas who founded this program, this has been responsible for Australia’s response to serious epidemic outbreaks in the past.

14 Nov 2010

U-M researchers develop simple mathematical model to predict whooping cough transmission

Strategies for preventing the spread of whooping cough on the rise in the United States and several other countries in recent years should take into account how often people in different age groups interact, research at the University of Michigan suggests.

12 Nov 2010

ACAAI scientific meeting to discuss pediatric allergies

Your child may be allergic to your holiday pumpkin pie, according to allergists at the annual scientific meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Phoenix, Nov. 11-16. Hot topics discussed in pediatric allergies include pumpkin and caterpillar allergies, and outgrowing childhood allergies.

12 Nov 2010

Scientists to present new findings from NIAID-funded research at ACAAI Annual Meeting

The 2010 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) brings together leading allergists and immunologists from around the world.

12 Nov 2010

Inovio to update HVTN 080 Phase I clinical study for HIV at HVTN Conference

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Dr. Spyros Kalams will provide an update of interim immune responses and safety results from the HVTN 080 Phase I clinical study of Inovio's PENNVAX-B HIV DNA vaccine in a preventive setting.

12 Nov 2010

Alcohol damages liver, weakens immune system, slows healing, impairs bone formation, and much more

Alcohol does much more harm to the body than just damaging the liver. Drinking also can weaken the immune system, slow healing, impair bone formation, increase the risk of HIV transmission and hinder recovery from burns, trauma, bleeding and surgery.

12 Nov 2010

Urgent action needed to prevent and treat childhood pneumonia

A Pneumonia Report Card released today by the International Vaccine Access Center (IVAC) on behalf of the Global Coalition against Child Pneumonia reveals where urgent efforts are needed to reach target levels of coverage for the life-saving interventions that can prevent, protect against and treat pneumonia in children.

12 Nov 2010

SLIT immunotherapy effective for long-term remission of bothersome allergy symptoms

Antihistamines and nasal steroids offer good short-term options for people with mild allergy, but allergy immunotherapy, better known as "allergy shots," is a preferred method for achieving long term remission of more bothersome allergy symptoms. Allergists mark the 100th anniversary of immunotherapy and present the latest advances at the American College of Allergy, Asthma and Immunology (ACAAI) annual scientific meeting in Phoenix, Nov. 11-16.

12 Nov 2010

Lancet series focuses on chronic diseases, development

"Just a small percentage of low- and middle-income countries' health care budgets are allocated toward the treatment and prevention of chronic diseases even though such illnesses are expected to account for 69% of global deaths by 2030," according to a paper published Wednesday in the Lancet, as part of a series on chronic disease and development, ModernHealthcare.com reports.

12 Nov 2010

Disease/Infection News

Inovio third quarter total revenue decreases from $3.6 million to $1.3 million

Researchers find influenza vaccines can contain allergenic components

Novel light technology kills hospital superbugs

WHO endorses low tech, low cost, rapid test for multi-drug resistant TB

Deinobiotics project receives €1.35 million for developing novel antibiotic, antifungal compounds

Report documents increase in R&D projects on developing world diseases

New findings on HIV can help validate structure-based drug design approach

Research on E.Coli bacteria could help develop new vaccine for urinary tract infection

Immunitor completes V5 Phase IIb imm01 clinical trial enrollment for TB

Pneumonia Report Card shows prevention, treatment tools not widely adopted in countries where disease kills most children

U.N. agencies, Rotary International launch mass polio immunization campaign in Central Africa

Australian epidemics research programme to be disbanded

U-M researchers develop simple mathematical model to predict whooping cough transmission

ACAAI scientific meeting to discuss pediatric allergies

Scientists to present new findings from NIAID-funded research at ACAAI Annual Meeting

Inovio to update HVTN 080 Phase I clinical study for HIV at HVTN Conference

Alcohol damages liver, weakens immune system, slows healing, impairs bone formation, and much more

Urgent action needed to prevent and treat childhood pneumonia

SLIT immunotherapy effective for long-term remission of bothersome allergy symptoms

Lancet series focuses on chronic diseases, development

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News